ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,536, issued on July 22, was assigned to Mayo Foundation for Medical Education and Research (Rochester, Minn.).
"Method and apparatus for percutaneous epicardial ablation of cardiac ganglionated plexi without myocardial injury" was invented by Samuel J. Asirvatham (Rochester, Minn.) and Mark B. Knudson (Shoreview, Minn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method and device for modulating the autonomic nervous system adjacent a pericardial space to treat cardiac arrhythmia includes a treatment source arranged to supply a treatment medium, a catheter having an end sized for insertion into the pericardial space, a medium delivery assembly h...